Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
Clinical trial NCT04634435 · COMPLETED
Trial details
- NCT number
- NCT04634435
- Sponsor
- Biohaven Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-21
- Primary completion
- 2025-01-10
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.